Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004616088 | SCV005104802 | uncertain significance | Inborn genetic diseases | 2024-06-02 | criteria provided, single submitter | clinical testing | The c.9181G>T (p.D3061Y) alteration is located in exon 58 (coding exon 58) of the CUBN gene. This alteration results from a G to T substitution at nucleotide position 9181, causing the aspartic acid (D) at amino acid position 3061 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005038742 | SCV005670691 | uncertain significance | Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign | 2024-03-28 | criteria provided, single submitter | clinical testing |